Characterization of 7A7, an anti-mouse EGFR monoclonal antibody proposed to be the mouse equivalent of cetuximab

The Epidermal Growth Factor Receptor (EGFR) is selectively expressed on the surface of numerous tumours, such as non-small cell lung, ovarian, colorectal and head and neck carcinomas. EGFR has therefore become a target for cancer therapy. Cetuximab is a chimeric human/mouse monoclonal antibody (mAb)...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xuzhi, Cruz, Jazmina L., Joseph, Shannon, Pett, Nicola, Chew, Hui Yi, Tuong, Zewen K., Okano, Satomi, Kelly, Gabrielle, Veitch, Margaret, Simpson, Fiona, Wells, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844743/
https://www.ncbi.nlm.nih.gov/pubmed/29552307
http://dx.doi.org/10.18632/oncotarget.24242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844743/
https://www.ncbi.nlm.nih.gov/pubmed/29552307
http://dx.doi.org/10.18632/oncotarget.24242

Ejemplares similares